<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04250906200141</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI181DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:15.944Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200158</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI221DE-VSG</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:15.911Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200165</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI301DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:15.885Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-100012483E</udiDi>
    <basicUdiDi>B-100012483E</basicUdiDi>
    <tradeName>FIDIAL PLUS</tradeName>
    <deviceName>FIDIAL PLUS</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001248</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:35:00.571Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-100011602X</udiDi>
    <basicUdiDi>B-100011602X</basicUdiDi>
    <tradeName>VITREAL S</tradeName>
    <deviceName>VITREAL S</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030201</emdnCode>
    <emdnDescription>OPHTHALMIC DYES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001160</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:34:49.991Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-100011612Z</udiDi>
    <basicUdiDi>B-100011612Z</basicUdiDi>
    <tradeName>VITREAL S</tradeName>
    <deviceName>VITREAL S</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030201</emdnCode>
    <emdnDescription>OPHTHALMIC DYES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001161</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:34:48.497Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-1000114533</udiDi>
    <basicUdiDi>B-1000114533</basicUdiDi>
    <tradeName>VITREAL S</tradeName>
    <deviceName>VITREAL S</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030201</emdnCode>
    <emdnDescription>OPHTHALMIC DYES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001145</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:34:31.397Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-100011162U</udiDi>
    <basicUdiDi>B-100011162U</basicUdiDi>
    <tradeName>FIDIAL PLUS</tradeName>
    <deviceName>FIDIAL PLUS</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001116</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:34:30.606Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-100010522T</udiDi>
    <basicUdiDi>B-100010522T</basicUdiDi>
    <tradeName>VITREAL S</tradeName>
    <deviceName>VITREAL S</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030201</emdnCode>
    <emdnDescription>OPHTHALMIC DYES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001052</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-10T21:34:24.192Z</lastUpdated>
  </row>
  <row>
    <udiDi>09003585000275</udiDi>
    <basicUdiDi>B-09003585000275</basicUdiDi>
    <tradeName>iGel Eye Drops</tradeName>
    <deviceName>iGel Eye Drops</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>09003585000275</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-10T19:30:00.753Z</lastUpdated>
  </row>
  <row>
    <udiDi>08906042081262</udiDi>
    <basicUdiDi>B-08906042081262</basicUdiDi>
    <tradeName>Sicalub</tradeName>
    <deviceName>Sterile Lubricating Eye Ointment</deviceName>
    <manufacturerName>Brassica Pharma Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000042789</manufacturerSrn>
    <authorisedRepresentativeName>Crescent Pharma International ltd.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000038910</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>ELM/030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-10T17:13:44.640Z</lastUpdated>
  </row>
  <row>
    <udiDi>08905702001800</udiDi>
    <basicUdiDi>B-08905702001800</basicUdiDi>
    <tradeName>QUIES OPTIK Solution Multifonctions Pour lentilles de contact Souples (Multifunction Solution for Soft Contact Lenses)</tradeName>
    <deviceName>QUIES OPTIK Solution Multifonctions Pour lentilles de contact Souples (Multifunction Solution for Soft Contact Lenses)</deviceName>
    <manufacturerName>STERICON PHARMA PVT.LTD</manufacturerName>
    <manufacturerSrn>IN-MF-000028275</manufacturerSrn>
    <authorisedRepresentativeName>MYM SOPORTE TECNICO Y DE CALIDAD, S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000017300</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030204</emdnCode>
    <emdnDescription>CONTACT LENSES STORING AND CLEANING SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NA</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-10T16:38:07.860Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100261</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.85mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:25.084Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100377</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.4mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:25.055Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100384</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-0.55mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:25.028Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100391</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>20mg/mL-1.0mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:25.003Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100605</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.4mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.980Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100759</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.55mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.947Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100797</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.85mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.913Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861105112</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.55mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-09T18:29:24.862Z</lastUpdated>
  </row>
</eudamedExport>